{"nct_id":"NCT05829226","title":"A Phase 1 Study With LYT-200 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML), or With Relapsed/Refractory, High-risk Myelodysplastic Syndrome (MDS)","status":"RECRUITING","status_verified_date":"2025-05","start_date":"2022-12-12","start_date_type":"ACTUAL","primary_completion_date":"2025-12","primary_completion_date_type":"ESTIMATED","completion_date":"2026-03","completion_date_type":"ESTIMATED","phases":["PHASE1"],"tickers":["PRTC"]}